Pyrotinib in HER2 heterogeneously mutated or amplified advanced non-small cell lung cancer patients: a retrospective real-world study (PEARL)

Autor: Yang, Guangjian, Hao, Xuezhi, Hu, Jiaqi, Dong, Keke, Xu, Haiyan, Yang, Lu, Zhang, Shuyang, Yang, Yaning, Xu, Fei, Li, Junling, Wang, Yan
Zdroj: In Journal of the National Cancer Center December 2021 1(4):139-146
Databáze: ScienceDirect